CCNB1 and lip and oral cavity carcinoma: To determine whether the kinase activity of PLK1 is involved in cancer cell proliferation, oral cancer cells were treated with the PLK1-specific inhibitor BI6727 to examine the CCNB1 expression/phosphorylation and cell proliferation (Figure 4).